Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation
Noninvasive ECOM Monitoring of Hemodynamic Parameters During Liver Transplantation
Sponsor: CONMED Corporation
Terminated
unable to complete statistical analysis
Other terminated trials from CONMED Corporation
More terminations from CONMED Corporation
Other Liver Transplantation trials with similar outcome
This observational or N/A phase trial investigates Liver Transplantation and is currently terminated or withdrawn. CONMED Corporation leads this study, which shows 8 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Sep 2023 — Jul 2024 [monthly]
Terminated
-
Jan 2021 — Sep 2023 [monthly]
Terminated
-
Jun 2018 — Jan 2021 [monthly]
Terminated
▶ Show 3 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
Apr 2017 — Apr 2018 [monthly]
Terminated NA
Status: Active Not Recruiting → Terminated
-
Jan 2017 — Apr 2017 [monthly]
Active Not Recruiting NA
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- CONMED Corporation
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .